|
|
|
Yubo International Biotech Limited (MAGAA) |
|
Yubo International Biotech Limited
MAGAA's Fundamental analysis
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
|
Yubo International Biotech Limited's sales fell
by -85.17 % in III. Quarter 2022 from the same quarter a year ago.
Ranking at No. 3289
Medical Equipment & Supplies industry recorded
growth of revenues by 1.98 %
Yubo International Biotech Limited net loss deacreased by in III. Quarter 2022 year on year, Yubo International Biotech Limited net loss increased by -29.26 % in III. Quarter 2022 year on year,
• More on MAGAA's Growth
|
|
Yubo International Biotech Limited
reported net loss of -2 millions in the past twelve months.
Company is currently trading with Price to Cash flow multiple of 5140.95 in trailing twelve-month period. |
| | | |
